Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of British Columbia
With
Canadian Institutes of Health Research (CIHR)
Multiple Sclerosis Society of Canada
Overview of study objectives are:
* To determine the safety and tolerability of venoplasty of CCSVI in Multiple Sclerosis (MS).
* To determine the short term and long term impact on validated patient measures and by physician and radiologic reported MS outcomes.
* To determine the short term and long term recurrence rate of CCSVI for veins that have been treated with venoplasty
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) or Secondary Progressive MS according to the McDonald criteria 2010
Age 18 to 65 years inclusive
Neurostatus (EDSS) score at screening from 0 to 6.5
Fulfill ultrasound criteria for CCSVI
You may not be if
Previous venoplasty and/or stenting of extra cranial venous system
